The appointment of Robert F. Kennedy Jr. as Secretary of the Department of Health and Human Services (HHS) heralds significant changes for the biotech, pharmaceutical, and medtech industries. Known for his skepticism toward certain vaccine protocols and a commitment to regulatory overhaul, RFK Jr.’s leadership introduces both opportunities and challenges for companies operating within this…

Picture this: A towering skyscraper in New York, a priceless painting in Paris, a bundle of carbon credits logged deep in a tropical rainforest, all seamlessly woven into a decentralized digital marketplace, traded at the click of a button from anywhere in the world.

Welcome to Real-World Asset (RWA) Tokenization 2.0, the next evolution in…

The cannabis plant has always been a canvas for innovation, but now, growers are stepping into the realm of genetic artistry. In fields and greenhouses around the world, gene editing is quietly transforming how we grow, protect, and perfect this ancient crop.

With the arrival of technologies like CRISPR, cultivators are no longer limited to…

The cannabis trade is stepping into its next chapter. Once dominated by North America and parts of Europe, the global marketplace is now rapidly expanding. African nations and Latin American alliances are reshaping the playing field, bringing both new opportunities and fresh challenges for industry leaders and policymakers alike.

Africa’s Growing Influence in the Cannabis…

The University of Kentucky (UK) Cannabis Center is leading the charge in advancing our understanding of cannabis and its diverse applications. By leveraging cutting-edge technology and a multidisciplinary research approach, the center is establishing a robust research pipeline that addresses the medicinal, social, and economic dimensions of cannabis use. With a commitment to evidence-based science,…

The Biden administration’s AI governance focused on striking a balance between innovation and safety, emphasizing ethical AI principles and public rights protection. His executive order introduced initial national standards aimed at addressing concerns like misinformation, election integrity, and non-consensual uses of AI. This framework was designed to ensure that AI could be scalable and innovative…

Psychedelics have long captured the imagination of researchers and the public alike, but now, advances in synthetic biology and biosynthesis are redefining what these compounds can achieve. By precision-engineering psychedelic compounds, scientists can better target neurological pathways and minimize side effects. Additionally, the biosynthetic production of substances like psilocybin is enabling large-scale manufacturing, reducing our…